SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-16-625162
Filing Date
2016-06-17
Accepted
2016-06-17 17:29:08
Documents
16

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d207633ds3.htm S-3 416878
2 EX-1.2 d207633dex12.htm EX-1.2 202797
3 EX-4.3 d207633dex43.htm EX-4.3 293070
4 EX-4.5 d207633dex45.htm EX-4.5 105905
5 EX-4.6 d207633dex46.htm EX-4.6 106447
6 EX-4.7 d207633dex47.htm EX-4.7 95222
7 EX-5.1 d207633dex51.htm EX-5.1 28923
8 EX-10.1 d207633dex101.htm EX-10.1 303304
9 EX-10.2 d207633dex102.htm EX-10.2 155741
10 EX-12.1 d207633dex121.htm EX-12.1 6123
11 EX-23.1 d207633dex231.htm EX-23.1 1836
12 EX-23.2 d207633dex232.htm EX-23.2 1622
13 GRAPHIC g207633g02c13.jpg GRAPHIC 6133
14 GRAPHIC g207633g08c20.jpg GRAPHIC 36896
15 GRAPHIC g207633g32n73.jpg GRAPHIC 33246
16 GRAPHIC g207633g59n40.jpg GRAPHIC 37770
  Complete submission text file 0001193125-16-625162.txt   1876353
Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-212114 | Film No.: 161720965
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1